More Transparency Needed for COVID-19 Emergency Authorizations

December 22/29, 2020, Vol 324, No. 24, Pages 2467-2566


Health Agencies Update
December 22/29, 2020
More Transparency Needed for COVID-19 Emergency Authorizations
Rita Rubin, MA
JAMA. 2020;324(24):2475. doi:10.1001/jama.2020.24201
To improve public trust, the US Food and Drug Administration (FDA) should be more transparent in publicly disclosing its reviews of safety and effectiveness data leading to Emergency Use Authorization (EUA) of coronavirus disease 2019 (COVID-19) vaccines and treatments, according to a recent report from the US Government Accountability Office (GAO)…